Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
JACC Case Rep ; 2(7): 1021-1024, 2020 Jun 17.
Artículo en Inglés | MEDLINE | ID: mdl-34317406

RESUMEN

Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital defect and usually diagnosed within the first 2 months of life. Only 10% of patients survive to adulthood largely in part to the formation of extensive collaterals from the right to left coronary arteries. We present a case of ALCAPA diagnosed in an asymptomatic adult through a transthoracic echocardiogram (TTE). (Level of Difficulty: Beginner.).

2.
J Clin Lipidol ; 9(3): 390-5, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26073399

RESUMEN

We report a novel heterozygous apolipoprotein A-I (apoA-I) missense mutation (c.517C>A, p.Arg149Ser, designated as apoA-IBoston) in a 67-year-old woman and her 2 sons, who had mean serum high-density lipoprotein (HDL) cholesterol, apoA-I, and apoA-I in very large α-1 HDL that were 10%, 35%, and 16% of normal, respectively (all P < .05). The percentage of HDL cholesterol in the esterified form was also significantly (P < .05) reduced to 52% of control values. Cholesteryl ester tranfer protein (CETP) activity was normal. The mean global, adenosine triphosphate (ATP)-binding cassette transporter A1 and scavenger receptor B type I-mediated cellular cholesterol efflux capacity in apoB-depleted serum from affected family members were 41%, 37%, 47%, 54%, and 48% of control values, respectively (all P < .05). lecithin-cholesterol acyltransferase (LCAT) activity in plasma was 71% of controls, whereas in the cell-based assay, it was 73% of control values (P < .05). The data indicate that this novel apoA-I missense is associated with markedly decreased levels of HDL cholesterol and very large α-1 HDL, as well as decreased serum cellular cholesterol efflux and LCAT activity, but not with premature coronary heart disease, similar to other apoA-I mutations that have been associated with decreased LCAT activity.


Asunto(s)
Apolipoproteína A-I/genética , Colesterol/metabolismo , Mutación Missense , Fosfatidilcolina-Esterol O-Aciltransferasa/metabolismo , Adulto , Anciano , Sustitución de Aminoácidos , Apolipoproteína A-I/metabolismo , Activación Enzimática/genética , Femenino , Humanos , Masculino , Fosfatidilcolina-Esterol O-Aciltransferasa/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA